Submit a Review & Earn an Amazon Gift Card
You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!
Submit ReviewGisadenafil besylate is a potent PDE5 inhibitor (IC50 = 1.23 nM). Shows >100-fold selectivity for PDE5 over PDE6. Orally bioavailable.
Sold for research purposes under agreement from Pfizer Inc.
Gisadenafil besylate is also offered as part of the Tocriscreen 2.0 Max. Find out more about compound libraries available from Tocris.
M. Wt | 677.79 |
Formula | C23H33N7O5S.C6H6O3S |
Storage | Desiccate at RT |
Purity | ≥99% (HPLC) |
CAS Number | 334827-98-4 |
PubChem ID | 23449797 |
InChI Key | STFRDYSZKVPPQF-UHFFFAOYSA-N |
Smiles | O=S(C1=CN=C(OCC)C(C3=NC(C2=NN(CCOC)C(CC)=C2N3)=O)=C1)(N4CCN(CC)CC4)=O.O=S(C5=CC=CC=C5)(O)=O |
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Solvent | Max Conc. mg/mL | Max Conc. mM | |
---|---|---|---|
Solubility | |||
water | 6.78 | 10 | |
DMSO | 67.78 | 100 |
The following data is based on the product molecular weight 677.79. Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.48 mL | 7.38 mL | 14.75 mL |
5 mM | 0.3 mL | 1.48 mL | 2.95 mL |
10 mM | 0.15 mL | 0.74 mL | 1.48 mL |
50 mM | 0.03 mL | 0.15 mL | 0.3 mL |
References are publications that support the biological activity of the product.
Hashim and Abrams (2010) Emerging drugs for the treatment of benign prostatic obstruction. Exp.Opin.Invest.Drugs 15 159 PMID: 20446824
Rawson et al (2012) The discovery of UK-369003, a novel PDE5 inhibitor with the potential for oral bioavailability and dose-proportional pharmacokinetics. Bioorg.Med.Chem. 20 498 PMID: 22100260
If you know of a relevant reference for Gisadenafil besylate, please let us know.
Keywords: Gisadenafil besylate, Gisadenafil besylate supplier, pfizer, phosphodiesterases, inhibitors, inhibits, PDE5, UK369003, UK, 369003, Phosphodiesterases, 4165, Tocris Bioscience
Citations are publications that use Tocris products. Selected citations for Gisadenafil besylate include:
Silva et al (2012) Transient hypercapnia reveals an underlying cerebrovascular pathology in a murine model for HIV-1 associated neuroinflammation: role of NO-cGMP signaling and normalization by inhibition of cyclic nucleotide phosphodiesterase-5. J Neuroinflammation 9 253 PMID: 23167821
Do you know of a great paper that uses Gisadenafil besylate from Tocris? Please let us know.
There are currently no reviews for this product. Be the first to review Gisadenafil besylate and earn rewards!
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image